Literature DB >> 10543657

Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

.   

Abstract

Routine vaccination of children is the most effective way to reduce hepatitis A incidence nationwide over time. Since licensure of hepatitis A vaccine in 1995, this strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest rates of infection and disease. These updated recommendations represent the next phase of this hepatitis A immunization strategy. Vaccination of children living in states and communities with consistently elevated rates of hepatitis A will provide protection from disease and is expected to reduce the overall incidence of hepatitis A. This report updates the ACIP's 1996 recommendations on the prevention of hepatitis A through immunization (MMWR 1996;45:[No. RR-151) and includes a) new data about the epidemiology of hepatitis A; b) recent findings about the effectiveness of community-based hepatitis A vaccination programs; and c) recommendations for the routine vaccination of children in states, counties, and communities with rates that are twice the 1987-1997 national average or greater (i.e., > or = 20 cases per 100,000 population) and consideration of routine vaccination of children in states, counties, and communities with rates exceeding the 1987-1997 national average (i.e., > or = 10 but <20 cases per 100,000 population). Unchanged in this report are previous recommendations regarding the vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543657

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  100 in total

Review 1.  The place of accelerated schedules for hepatitis A and B vaccinations.

Authors:  Jane Zuckerman
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Using an integrated approach to understand vaccination behavior among young men who have sex with men: stages of change, the health belief model, and self-efficacy.

Authors:  Scott D Rhodes; Kenneth C Hergenrather
Journal:  J Community Health       Date:  2003-10

3.  Hepatitis a epidemiology goes global.

Authors:  Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

4.  Hepatitis A Infections Among Food Handlers in the United States, 1993-2011.

Authors:  Umid M Sharapov; Karine Kentenyants; Justina Groeger; Henry Roberts; Scott D Holmberg; Melissa G Collier
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

5.  Physician Knowledge and Attitudes About Hepatitis A and Current Practices Regarding Hepatitis A Vaccination Delivery.

Authors:  Noele P Nelson; Mandy A Allison; Megan C Lindley; Michaela Brtnikova; Lori A Crane; Brenda L Beaty; Laura P Hurley; Allison Kempe
Journal:  Acad Pediatr       Date:  2017-01-09       Impact factor: 3.107

6.  Immunization needs of chronic liver disease patients seen in primary care versus specialist settings.

Authors:  R Jake Jacobs; Allen S Meyerhoff; Sammy Saab
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 7.  Should all children be immunised against hepatitis A?

Authors:  Jonathan L Temte
Journal:  BMJ       Date:  2006-03-25

Review 8.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

9.  Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.

Authors:  Xin Yue; Carla L Black; Alissa O'Halloran; Peng-Jun Lu; Walter W Williams; Noele P Nelson
Journal:  Vaccine       Date:  2018-02-21       Impact factor: 3.641

10.  Hepatitis A virus immunity and seroconversion among contacts of acute hepatitis A patients in Amsterdam, 1996-2000: an evaluation of current prevention policy.

Authors:  Gerard J B Sonder; Jim E van Steenbergen; Lian P M J Bovee; Paul G H Peerbooms; Roel A Coutinho; Anneke van den Hoek
Journal:  Am J Public Health       Date:  2004-09       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.